OpenVSafe by OpenVAERS
Search V-safe

K8K-33556-71675

2 vaccinations 1 coded response 14 check-ins 0 free-text entries 1 call case
Sex
Female
Age at first dose
0-4
ZIP prefix
751 / TX
Registered
2022-10-02
Relationship
Child or adolescent in my care
Guardian
4GT-33339-62308
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-09-30
    Dose 1 — Pfizer-BioNTech
  2. 2022-10-02
    Registered in v-safe
  3. 2022-10-02
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-10-05
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-10-09
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-10-14
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  7. 2022-10-23
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  8. 2022-10-25
    Dose 2 — Pfizer-BioNTech
  9. 2022-10-28
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Irritability/crying
    Under 3 check-in
  10. 2022-10-30
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  11. 2022-10-31
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  12. 2022-11-03
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  13. 2022-11-08
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  14. 2022-11-22
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  15. 2022-12-06
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  16. 2023-01-26
    Health check-in — 3 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  17. 2023-04-25
    Survey response — 6 months, dose 2, under 3
    MedDRA: Amblyopia, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  18. 2023-04-25
    Report sent to call center — 6 months, dose 2, under 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  19. 2023-04-26

Vaccinations

DoseDateManufacturerCo-administered
12022-09-30Pfizer-BioNTech No
22022-10-25Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2023-04-25 Unsuccessful

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDAmblyopia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…